fda bpc-157 safety concerns compounding This is the first vote from the FDA's Pharmacy Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the will make NBC News | The claims

Is Wegovy the same as Saxenda or Mounjaro

The perikaryon, dendrites and spines

Real Results from Real Patients Our patients consistently report more energy, better sleep, leaner bodies, and sharper focus

The most common symptoms are flatulence and bloating as well as bloating after meals

Risk Management & CAPA Linkage FDA expects firms to connect the dots. Risk assessments must be robust, and CAPAs must address root causes and systemic issues, not just isolated events

Side Effects & Safety No lethal dose found -- toxicology studies couldn't establish an LD50 (Sikiric et al., 2006) No organ toxicity in chronic dosing No hormonal effects -- doesn't affect testosterone, estrogen, cortisol, or GH Mild nausea -- mostly with oral dosing Brief lightheadedness -- occasionally after injection Injection site redness -- standard for SC peptides Angiogenesis concern -- promotes new blood vessel growth, which raises a theoretical question about existing tumors